Xiaolei Liu

2.1k total citations
95 papers, 1.2k citations indexed

About

Xiaolei Liu is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Xiaolei Liu has authored 95 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 32 papers in Surgery and 17 papers in Oncology. Recurrent topics in Xiaolei Liu's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Vascular Malformations and Hemangiomas (11 papers) and Vascular Tumors and Angiosarcomas (9 papers). Xiaolei Liu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Vascular Malformations and Hemangiomas (11 papers) and Vascular Tumors and Angiosarcomas (9 papers). Xiaolei Liu collaborates with scholars based in China, United States and Sweden. Xiaolei Liu's co-authors include Bin Jiao, Lu Shen, Zhiying Yang, Yuguang Shi, Haidong Tan, Jia Nie, Shuang Si, Zeneng Cheng, Leonard S. Jefferson and Scot R. Kimball and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaolei Liu

89 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolei Liu China 20 581 258 196 180 152 95 1.2k
Bruno Baudin France 24 647 1.1× 225 0.9× 163 0.8× 206 1.1× 168 1.1× 80 1.9k
Xiang Chen China 21 757 1.3× 126 0.5× 151 0.8× 132 0.7× 209 1.4× 74 1.5k
Yujun Shen China 22 498 0.9× 124 0.5× 127 0.6× 145 0.8× 151 1.0× 52 1.3k
Teresa Infante Italy 24 657 1.1× 277 1.1× 97 0.5× 169 0.9× 255 1.7× 56 1.6k
Yanlin Wang China 26 737 1.3× 286 1.1× 146 0.7× 125 0.7× 120 0.8× 91 2.0k
Hao Lu China 22 628 1.1× 276 1.1× 125 0.6× 110 0.6× 168 1.1× 144 1.7k
Arnaud Bruneel France 17 637 1.1× 137 0.5× 137 0.7× 134 0.7× 135 0.9× 54 1.3k
Zhenyu Wang China 23 698 1.2× 307 1.2× 230 1.2× 89 0.5× 305 2.0× 131 1.8k
Da‐Zhi Chen China 21 772 1.3× 243 0.9× 409 2.1× 147 0.8× 260 1.7× 81 1.7k
Xin Wei China 22 574 1.0× 248 1.0× 143 0.7× 136 0.8× 176 1.2× 92 1.8k

Countries citing papers authored by Xiaolei Liu

Since Specialization
Citations

This map shows the geographic impact of Xiaolei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolei Liu more than expected).

Fields of papers citing papers by Xiaolei Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolei Liu. The network helps show where Xiaolei Liu may publish in the future.

Co-authorship network of co-authors of Xiaolei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolei Liu. A scholar is included among the top collaborators of Xiaolei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolei Liu. Xiaolei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Huan, Srinivas Chatla, Xiaolei Liu, et al.. (2025). ZNF251 haploinsufficiency confers PARP inhibitors resistance in BRCA1-mutated cancer cells through activation of homologous recombination. Cancer Letters. 613. 217505–217505. 3 indexed citations
3.
4.
Zhang, Rong, Wei Zhu, Xiaolei Liu, et al.. (2024). Mutant kri1l causes abnormal retinal development via cell cycle arrest and apoptosis induction. Cell Death Discovery. 10(1). 251–251. 1 indexed citations
5.
Liu, Xiaolei, et al.. (2024). Total synthesis of (±)-3-demethoxyerythratidinone via Tf2O-promoted cascade reaction of enaminone. Chemical Communications. 60(28). 3842–3845. 3 indexed citations
6.
Zhang, Gongchang, Fengjuan Hu, Xiaoqing Ma, et al.. (2024). The recent development, application, and future prospects of muscle atrophy animal models. SHILAP Revista de lepidopterología. 3(4). 2 indexed citations
7.
Liu, Li‐Han, Li Wang, Xiaolei Liu, et al.. (2024). Elucidating the potential of isorhapontigenin in targeting the MgrA regulatory network: a paradigm shift for attenuating MRSA virulence. Antimicrobial Agents and Chemotherapy. 68(9). e0061124–e0061124. 2 indexed citations
8.
Chang, Zhiwei, Yongxu Jia, Ming Gao, et al.. (2024). PHF5A promotes esophageal squamous cell carcinoma progression via stabilizing VEGFA. Biology Direct. 19(1). 19–19. 1 indexed citations
10.
Sun, Xuelian, Yu Liu, Meiling Ge, et al.. (2022). Plasma metabolomics and lipidomics signatures of motoric cognitive risk syndrome in community-dwelling older adults. Frontiers in Aging Neuroscience. 14. 977191–977191. 5 indexed citations
11.
Xia, Xin, et al.. (2022). Nutrition mediates the relationship between number of teeth and sarcopenia: a pathway analysis. BMC Geriatrics. 22(1). 649–649. 7 indexed citations
12.
Zhang, Xiaolu, Xiaolei Liu, Wei Xie, et al.. (2022). Possible Involvement of DNA Methylation in TSC1 Gene Expression in Neuroprotection Induced by Hypoxic Preconditioning. Oxidative Medicine and Cellular Longevity. 2022(1). 9306097–9306097. 3 indexed citations
13.
Du, Xueting, Shengwei Xiao, Qiang Luo, Xiaolei Liu, & Jie Liu. (2021). Laminaria japonica cyclic peptides exert anti‐colorectal carcinoma effects through apoptosis induction in vitro and in vivo. Journal of Peptide Science. 28(5). e3385–e3385. 8 indexed citations
14.
Liu, Xiaolei, Zihuan Zhang, Jia Huang, Haidong Tan, & Zhiying Yang. (2021). Efficacy and Safety of Interferon-Alpha 2b for Patients with Hepatic Epithelioid Hemangioendothelioma: Outcomes of a Case-Series Analysis. Cancer Management and Research. Volume 13. 8273–8279. 10 indexed citations
15.
Chen, Wenwen, Jiaying Zheng, Shaoxiong Liu, et al.. (2019). Breast Cancer Subtype Classification Using 4-Plex Droplet Digital PCR. Clinical Chemistry. 65(8). 1051–1059. 21 indexed citations
16.
Liu, Liguo, Haidong Tan, Jia Huang, et al.. (2018). Laparoscopic partial splenectomy for splenic solid lesions. Zhonghua putong waike zazhi. 33(5). 398–400. 1 indexed citations
17.
Yang, Zhiying, Xiaolei Liu, Haidong Tan, & Liguo Liu. (2018). Lymphovascular tumor embolus might be a risk factor for peritoneal metastasis after laparoscopic hepatectomy for hepatocellular carcinoma. HepatoBiliary Surgery and Nutrition. 7(6). 503–504. 2 indexed citations
18.
Wang, Zhuo, Yuzhi Chen, Hui Zhang, et al.. (2018). Mitochondria-Targeting Polydopamine Nanocomposites as Chemophotothermal Therapeutics for Cancer. Bioconjugate Chemistry. 29(7). 2415–2425. 21 indexed citations
19.
Liu, Xiaolei, et al.. (2014). Lung ultrasonography: an effective way to diagnose community-acquired pneumonia. Emergency Medicine Journal. 32(6). 433–438. 61 indexed citations
20.
Zhang, Guoqiang, Haifeng Wang, Xiaolei Liu, et al.. (2013). Ultrasonographic measurement of inferior vena cava internal diameter and respiratory variation index as guidelines in fluid resuscitation of septic shock. Zhonghua jizhen yixue zazhi. 22(11). 1252–1255. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026